MedPath

Antipyretic effect of Ayurveda compound on fever in children

Phase 2/3
Not yet recruiting
Conditions
Unspecified infectious disease. Ayurveda Condition: JVARAH,
Registration Number
CTRI/2022/03/041337
Lead Sponsor
Dr Shraddha Detroja
Brief Summary

This trial is designed to evaluate the efficacy of Ayurveda Antipyretic for children

As there is need of hour to develop the Ayurveda antipyretic drug which act quickly

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
150
Inclusion Criteria
  1. Patient of either gender suffering from fever of age 5 to 12 years 2) Acute onset fever of 1 to 3 days 3) Temperature between 99 to 103 Fahrenheit 4) Children with parents who agree to participate and sign the informed consent.
Exclusion Criteria
  1. Fever more than 103 Fahrenheit 2) Any febrile condition of children requiring an immediate intervention depending on history and general condition at the point of examination as found by the investigator will be excluded from study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in Fever and body temperatureAt base line | On Day 2 | Day 3 | Day 5
Reduction in body ache and headacheAt base line | On Day 2 | Day 3 | Day 5
improvement in appetiteAt base line | On Day 2 | Day 3 | Day 5
Secondary Outcome Measures
NameTimeMethod
improvement in Leg crampsImprovement in weakness

Trial Locations

Locations (1)

Parul Ayurveda Hospital

🇮🇳

Vadodara, GUJARAT, India

Parul Ayurveda Hospital
🇮🇳Vadodara, GUJARAT, India
Dr Shraddha Detroja
Principal investigator
9265777066
shraddhadetroja@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.